Insider Transactions Reported by 14 Insiders of Vericel Corp

Symbol
VCEL on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Vericel Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dominick Colangelo President and CEO, Director $13,504,078 -$5,689,517 -30% 18 Feb 2026
Jonathan Mark Hopper Chief Medical Officer $3,125,750 -$1,318,559 -30% 18 Feb 2026
Alan L. Rubino Director $2,109,852 30 Apr 2025
Michael Halpin Chief Operating Officer $1,600,363 -$1,304,541 -45% 18 Feb 2026
Heidi Hagen Director $1,478,747 -$445,770 -23% 30 Apr 2025
Joseph Anthony Mara Jr Chief Financial Officer $1,447,102 -$445,770 -24% 18 Feb 2026
ROBERT L. ZERBE MD Director $1,387,052 30 Apr 2025
Paul K. Wotton Director $968,523 -$189,500 -16% 02 Dec 2025
Sean Flynn Chief Legal Officer $620,776 -$86,905 -12% 18 Feb 2026
LISA WRIGHT Director $564,487 30 Apr 2025
KEVIN F. MCLAUGHLIN Director $523,365 -$1,044,050 -67% 11 Feb 2026
STEVEN C. GILMAN Director $512,560 16 Oct 2024
JONATHAN SIEGAL Principal Accounting Officer $464,470 -$59,204 -11% 18 Feb 2026
Karen Mahoney Chief Human Resources Officer $70,414 22 Jul 2025

Recent Insider Transactions by Companies or Individuals for Vericel Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.